GANESHBE

Ganesh Benzoplast Share Price

₹134.23 -0.96 (-0.71%)

28 Dec, 2024 01:26

SIP TrendupStart SIP in GANESHBE

Start SIP

Performance

  • Low
  • ₹133
  • High
  • ₹136
  • 52 Week Low
  • ₹127
  • 52 Week High
  • ₹217
  • Open Price₹135
  • Previous Close₹135
  • Volume44,169

Investment Returns

  • Over 1 Month + 2.4%
  • Over 3 Month -7.87%
  • Over 6 Month -10.65%
  • Over 1 Year -15.87%
SIP Lightning

Smart Investing Starts Here Start SIP with Ganesh Benzoplast for Steady Growth!

Invest Now

Ganesh Benzoplast Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 15.3
  • PEG Ratio
  • 3.1
  • Market Cap Cr
  • 966
  • P/B Ratio
  • 1.9
  • Average True Range
  • 5.58
  • EPS
  • 8.79
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.23
  • RSI
  • 42.49
  • MFI
  • 73.19

Ganesh Benzoplast Financials

Ganesh Benzoplast Technicals

EMA & SMA

Current Price
₹134.23
-0.96 (-0.71%)
pointer
  • stock-down_img
  • Bullish Moving Average 0
  • stock-up_img
  • Bearish Moving Average 16
  • 20 Day
  • ₹138.65
  • 50 Day
  • ₹140.79
  • 100 Day
  • ₹145.91
  • 200 Day
  • ₹151.93

Resistance and Support

134.51 Pivot Speed
  • R3 138.69
  • R2 137.39
  • R1 135.81
  • S1 132.93
  • S2 131.63
  • S3 130.05

What's your outlook on Ganesh Benzoplast?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Ganesh Benzoplast Ltd. manufactures and supplies specialty chemicals and food preservatives, including benzoic acid and sodium benzoate. It also offers liquid storage terminal services, serving industries like food, pharmaceuticals, and petrochemicals across domestic and international markets.

Ganesh Benzoplast has an operating revenue of Rs. 437.61 Cr. on a trailing 12-month basis. An annual revenue growth of 14% is good, Pre-tax margin of 18% is great, ROE of 12% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 47 which is a POOR score indicating inconsistency in earnings, a RS Rating of 16 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 83 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of D is close to being the worst. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Ganesh Benzoplast Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-14 Quarterly Results
2024-08-12 Quarterly Results & A.G.M.
2024-05-30 Audited Results
2024-02-12 Quarterly Results
2024-01-29 Others

Ganesh Benzoplast F&O

Ganesh Benzoplast Shareholding Pattern

39.02%
5.08%
0%
40.9%
15%

About Ganesh Benzoplast

  • NSE Symbol
  • GANESHBE
  • BSE Symbol
  • 500153
  • Chairman & Managing Director
  • Mr. Rishi Ramesh Pilani
  • ISIN
  • INE388A01029

Similar Stocks to Ganesh Benzoplast

Ganesh Benzoplast FAQs

Ganesh Benzoplast share price is ₹134 As on 28 December, 2024 | 01:12

The Market Cap of Ganesh Benzoplast is ₹966.3 Cr As on 28 December, 2024 | 01:12

The P/E ratio of Ganesh Benzoplast is 15.3 As on 28 December, 2024 | 01:12

The PB ratio of Ganesh Benzoplast is 1.9 As on 28 December, 2024 | 01:12

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23